Search
forResearch 10 of 562
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
- The Relationship Between Depression Levels and Suicide Risk in Pediatric Patients with Alopecia Areata and the Oxidant-Antioxidant Balance
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Finasteride. dutasteride risk of suicide and sexual dysfunction
- Finasteride, pharmacogenomics, and suicide risk: a public health concern
- Finasteride-Induced Neuropsychiatric Reactions Are Well Established
- Finasteride-Induced Neuropsychiatric Reactions Are Well Established
- Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: a call for enhanced vigilance
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
Community 2
- Popular hair loss drug linked to higher suicide risk: compared to non-users, finasteride (Proscar/ Propecia) users have a markedly increased risk of depression, anxiety, and suicidal thoughts. Over 30 years of observation, 19,320 suicides were expected.
- Dermatologist says finasteride is no longer prescribed after apothecaries warning (Austria)
Learn
— no results
Try a deeper search in learn →